Szalay Aladar
SEC CIK 1937513 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GNLX | GENELUX Corp | 10% | 632.9K | — | $11.81M | 23 | 2023-01-30 | 2024-09-12 |
Most active insiders at GNLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zindrick Thomas | Pres, CEO | — | $117.7K |
| 2 | Thomas John | Dir | — | $108.8K |
| 3 | Smither John W | Dir | — | $34.9K |
| 4 | Cappello Joseph | Chief Technical Off | — | $34.0K |
| 5 | Yu Yong | SVP, Clinical Development | — | $32.6K |
| 6 | Smalling Ralph | Head of Regulatory | — | $2,804 |
| 7 | Pulisic Matthew | CFO | — | — |
| 8 | Mirabelli Mary | Dir | — | — |
| 9 | Groen Eric | GC | — | — |
| 10 | Tyree James L | Dir | — | — |
Szalay Aladar made no open-market trades at GNLX in the last 12 months.
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-09-13 | 2024-09-12+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $2.65 | -64.9K | 632.9K | -9% | -$171.8K |
| MI | 2024-09-11 | 2024-09-09+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $2.62 | -75.1K | 664.7K | -10% | -$196.5K |
| I | 2024-09-06 | 2024-09-03 | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $2.09 | -42.8K | 739.8K | -5% | -$89.5K |
| MI | 2024-08-30 | 2024-08-28+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $2.09 | -265.6K | 782.6K | -25% | -$554.0K |
| MI | 2024-08-27 | 2024-08-23+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $2.19 | -91.6K | 1.05M | -8% | -$200.5K |
| MI | 2024-05-15 | 2024-05-13+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $3.62 | -36.0K | 1.16M | -3% | -$130.3K |
| MI | 2024-05-09 | 2024-05-07+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $3.77 | -19.9K | 1.19M | -2% | -$75.3K |
| MI | 2024-05-01 | 2024-04-29+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $3.23 | -60.0K | 1.20M | -5% | -$194.0K |
| MI | 2024-04-24 | 2024-04-22+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $3.50 | -44.4K | 1.26M | -3% | -$155.6K |
| MI | 2024-04-18 | 2024-04-16+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $3.59 | -71.4K | 1.30M | -5% | -$256.2K |
| I | 2023-10-26 | 2023-10-25 | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $19.40 | -5,704 | 1.37M | -0.4% | -$110.7K |
| I | 2023-10-25 | 2023-10-23 | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $19.97 | -50.0K | 1.38M | -4% | -$998.2K |
| MI | 2023-10-10 | 2023-10-05 | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $24.93 | -14.3K | 1.43M | -1.0% | -$355.3K |
| I | 2023-10-04 | 2023-10-03 | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $25.49 | -75.7K | 1.44M | -5% | -$1.93M |
| MI | 2023-09-29 | 2023-09-27+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $24.41 | -13.5K | 1.52M | -0.9% | -$330.7K |
| MI | 2023-09-27 | 2023-09-25+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $24.38 | -42.3K | 1.56M | -3% | -$1.03M |
| MI | 2023-09-25 | 2023-09-21+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $27.85 | -16.6K | 1.59M | -1% | -$462.0K |
| MI | 2023-09-20 | 2023-09-18 | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $23.29 | -30.3K | 7,927 | -79% | -$705.6K |
| M | 2023-09-20 | 2023-09-19 | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $26.45 | -32.2K | 8,247 | -80% | -$850.9K |
| MI | 2023-09-15 | 2023-09-13+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $21.80 | -44.3K | 35.3K | -56% | -$965.8K |
| MI | 2023-09-13 | 2023-09-11+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $22.23 | -52.6K | 122.9K | -30% | -$1.17M |
| MI | 2023-09-11 | 2023-09-07+ | GNLX | GENELUX Corp | Szalay Aladar | 10% | S - Sale | $23.57 | -37.3K | 134.9K | -22% | -$878.7K |
| DMI | 2023-01-30 | 2023-01-30 | GNLX | GENELUX Corp | Szalay Aladar | 10% | C - Cnv Deriv | — | +1.00M | 2.26M | +79% | — |
Purchase Sale Sale after option exercise All abbreviations